Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-11-12 11:46 am Unchanged |
2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
BLACKROCK INC BLK |
3,122,570 5.200% |
0 (Unchanged) |
Filing History |
2024-11-05 4:12 pm Purchase |
2024-10-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
PRUDENTIAL FINANCIAL INC PRU |
7,418,762 11.000% |
1,137,033![]() (+18.10%) |
Filing History |
2024-11-05 3:32 pm Purchase |
2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
PRUDENTIAL FINANCIAL INC PRU |
6,281,729 9.300% |
6,281,729![]() (New Position) |
Filing History |
2024-11-04 11:20 am Purchase |
2024-10-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
JENNISON ASSOCIATES LLC | 6,993,422 10.400% |
6,993,422![]() (New Position) |
Filing History |
2024-10-21 4:11 pm Purchase |
2024-09-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
BLACKROCK INC BLK |
3,122,570 5.200% |
3,122,570![]() (New Position) |
Filing History |
2024-08-22 4:05 pm Purchase |
2024-08-20 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 12,788,710 18.000% |
2,618,922![]() (+25.75%) |
Filing History |
2024-06-06 1:59 pm Purchase |
2024-03-07 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,169,788 17.400% |
44,000![]() (+0.43%) |
Filing History |
2024-04-10 06:10 am Sale |
2024-04-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 2,790,480 4.800% |
-362,737![]() (-11.50%) |
Filing History |
2024-04-01 06:15 am Sale |
2024-03-28 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,153,217 5.400% |
-602,366![]() (-16.04%) |
Filing History |
2024-02-12 4:36 pm Purchase |
2023-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
3,496,808 6.100% |
561,702![]() (+19.14%) |
Filing History |
2024-02-09 11:45 am Purchase |
2024-02-07 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Invesco Ltd. IVZ |
3,167,653 5.500% |
960,004![]() (+43.49%) |
Filing History |
2024-01-26 4:00 pm Purchase |
2024-01-24 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Medicxi Growth I LP | 7,464,572 13.000% |
4,980,298![]() (+200.47%) |
Filing History |
2024-01-25 06:11 am Sale |
2024-01-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
TAKEDA PHARMACEUTICAL CO LTD | 3,755,583 6.600% |
-3,703,721![]() (-49.65%) |
Filing History |
2023-05-26 5:29 pm Purchase |
2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% |
1,697,683![]() (+20.14%) |
Filing History |
2023-05-05 4:13 pm Purchase |
2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% |
8,428,105![]() (New Position) |
Filing History |
2023-03-09 4:17 pm Purchase |
2023-03-01 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Carlyle Group Inc. CG |
2,935,106 6.700% |
2,935,106![]() (New Position) |
Filing History |
2023-02-14 1:58 pm Purchase |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Avidity Partners Management LP | 1,900,000 4.600% |
4,000![]() (+0.21%) |
Filing History |
2023-02-10 3:59 pm Sale |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Flynn James E | 0 0.000% |
-2,414,897![]() (Position Closed) |
Filing History |
2023-02-09 11:30 am Sale |
2022-12-30 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
The Vanguard Group | 1,076,605 2.590% |
-851,239![]() (-44.15%) |
Filing History |
2023-02-09 11:18 am Sale |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
JANUS HENDERSON GROUP PLC JHG |
2,952 0.000% |
-1,838,405![]() (-99.84%) |
Filing History |